Assignee
BIOCRYST PHARM INC
US·82 granted patents·30 pending applications·1,042 citations·filing 1994–2025
Top patents by PatentIndex Score
112 records- 0198US10662160B1Crystalline salts of a plasma kallikrein inhibitorBIOCRYST PHARM INC·Filed 2019·Granted May 26, 2020·17 cites·28 claims
- 0298US7560434B2AZA nucleosides, preparation thereof and use as inhibitors of RNA viral polymerasesBIOCRYST PHARM INC·Filed 2005·Granted Jul 14, 2009·92 cites·29 claims
- 0397US12344585B2Crystalline salts of a plasma kallikrein inhibitorBIOCRYST PHARM INC·Filed 2023·Granted Jul 1, 2025·6 cites·12 claims
- 0497US11618733B2Crystalline salts of a plasma kallikrein inhibitorBIOCRYST PHARM INC·Filed 2021·Granted Apr 4, 2023·7 cites·16 claims
- 0597US11230530B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2020·Granted Jan 25, 2022·5 cites·22 claims
- 0697US11203574B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2020·Granted Dec 21, 2021·5 cites·22 claims
- 0797US11192861B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2020·Granted Dec 7, 2021·5 cites·27 claims
- 0897US11117867B2Crystalline salts of a plasma kallikrein inhibitorBIOCRYST PHARM INC·Filed 2020·Granted Sep 14, 2021·8 cites·20 claims
- 0997US10689346B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2019·Granted Jun 23, 2020·10 cites·38 claims
- 1097US10633345B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2018·Granted Apr 28, 2020·10 cites·25 claims
- 1197US10329260B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2018·Granted Jun 25, 2019·26 cites·45 claims
- 1297US10125102B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2015·Granted Nov 13, 2018·24 cites·16 claims
- 1397US7994139B2Antiviral therapeutic agentsBIOCRYST PHARM INC·Filed 2009·Granted Aug 9, 2011·81 cites·24 claims
- 1497US7429571B2Therapeutic furopyrimidines and thienopyrimidinesBIOCRYST PHARM INC·Filed 2006·Granted Sep 30, 2008·84 cites·16 claims
- 1596US11708333B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Jul 25, 2023·2 cites·23 claims
- 1696US11708332B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Jul 25, 2023·2 cites·16 claims
- 1796US11685721B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Jun 27, 2023·2 cites·33 claims
- 1896US7514410B2Hepatitis C therapiesBIOCRYST PHARM INC·Filed 2006·Granted Apr 7, 2009·80 cites·42 claims
- 1996US7388002B2Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerasesBIOCRYST PHARM INC·Filed 2005·Granted Jun 17, 2008·39 cites·16 claims
- 2095US11708347B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Jul 25, 2023·3 cites·9 claims
- 2195US11370774B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Jun 28, 2022·4 cites·3 claims
- 2295US6699994B1Biaryl compounds as serine protease inhibitorsBIOCRYST PHARM INC·Filed 2002·Granted Mar 2, 2004·87 cites·21 claims
- 2394US11866418B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2022·Granted Jan 9, 2024·2 cites·17 claims
- 2494US2026092045A1Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2025·Application pending·0 cites
- 2593US12590069B2Crystalline salts of a plasma kallikrein inhibitorBIOCRYST PHARM INC·Filed 2025·Granted Mar 31, 2026·0 cites·30 claims
- 2693US12590068B2Crystalline salts of a plasma kallikrein inhibitorBIOCRYST PHARM INC·Filed 2025·Granted Mar 31, 2026·0 cites·30 claims
- 2793US12552750B2Crystalline salts of a plasma kallikrein inhibitorBIOCRYST PHARM INC·Filed 2025·Granted Feb 17, 2026·0 cites·28 claims
- 2893US12545646B2Crystalline salts of a plasma kallikrein inhibitorBIOCRYST PHARM INC·Filed 2025·Granted Feb 10, 2026·0 cites·28 claims
- 2993US12545645B2Crystalline salts of a plasma kallikrein inhibitorBIOCRYST PHARM INC·Filed 2025·Granted Feb 10, 2026·0 cites·28 claims
- 3093US12545647B2Crystalline salts of a plasma kallikrein inhibitorBIOCRYST PHARM INC·Filed 2025·Granted Feb 10, 2026·0 cites·28 claims
- 3193US11021458B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2019·Granted Jun 1, 2021·5 cites·12 claims
- 3292US6653340B1Compounds useful in the complement, coagulat and kallikrein pathways and method for their preparationBIOCRYST PHARM INC·Filed 1998·Granted Nov 25, 2003·88 cites·19 claims
- 3392US2025257040A1Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2024·Application pending·0 cites
- 3492US2025270171A1Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2024·Application pending·0 cites
- 3591US12043610B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2022·Granted Jul 23, 2024·1 cites·9 claims
- 3691US11559515B2Indole compounds and analogues thereofBIOCRYST PHARM INC·Filed 2020·Granted Jan 24, 2023·2 cites·19 claims
- 3791US6458799B1Deazaguanine analog, preparation thereof and use thereofBIOCRYST PHARM INC·Filed 2001·Granted Oct 1, 2002·36 cites·3 claims
- 3890US11173159B2Methods and compositions for inhibition of polymeraseBIOCRYST PHARM INC·Filed 2019·Granted Nov 16, 2021·3 cites·20 claims
- 3990US9492452B2Methods and compositions for inhibition of polymeraseBIOCRYST PHARM INC·Filed 2014·Granted Nov 15, 2016·9 cites·30 claims
- 4089US10420769B2Methods and compositions for inhibition of polymeraseBIOCRYST PHARM INC·Filed 2018·Granted Sep 24, 2019·4 cites·20 claims
- 4189US10022375B2Methods and compositions for inhibition of polymeraseBIOCRYST PHARM INC·Filed 2016·Granted Jul 17, 2018·5 cites·32 claims
- 4289US6936719B2Biaryl compounds as serine protease inhibitorsBIOCRYST PHARM INC·Filed 2003·Granted Aug 30, 2005·37 cites·18 claims
- 4389US6656915B1Inhibiting T-cell proliferationBIOCRYST PHARM INC·Filed 2000·Granted Dec 2, 2003·47 cites·9 claims
- 4489US6503745B1Cyclopentane and cyclopentene compounds and use for detecting influenza virusBIOCRYST PHARM INC·Filed 1999·Granted Jan 7, 2003·42 cites·39 claims
- 4588US12162838B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2023·Granted Dec 10, 2024·0 cites·28 claims
- 4688US12116346B2Human plasma kallikrein inhibitorsBIOCRYST PHARM INC·Filed 2023·Granted Oct 15, 2024·0 cites·26 claims
- 4787US10849883B2Benzopyrazole compounds and analogues thereofBIOCRYST PHARM INC·Filed 2017·Granted Dec 1, 2020·3 cites·21 claims
- 4887US5602277ASubstituted benzene derivatives useful as neuraminidase inhibitorsBIOCRYST PHARM INC·Filed 1995·Granted Feb 11, 1997·33 cites·25 claims
- 4987US2025388545A1Crystalline salts of a plasma kallikrein inhibitorBIOCRYST PHARM INC·Filed 2025·Application pending·0 cites
- 5086US11661426B2Imidazole-containing inhibitors of ALK2 kinaseBIOCRYST PHARM INC·Filed 2018·Granted May 30, 2023·2 cites·42 claims
Showing the top 50 of 112 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →